Nachrichten zur AstraZeneca PLC Aktie

AstraZeneca PLC (AZN) Q4 2025 Earnings Call Transcript

…

Heres What Key Metrics Tell Us About Astrazeneca (AZN) Q4 Earnings

The headline numbers for Astrazeneca (AZN) give insight into how the company performed in the quarter ended December 2025, but…

KORREKTUR/ROUNDUP: Astrazeneca will 2026 mehr verdienen - Aktie nahe Rekordhoch

(Es wird in der Überschrift und im 1. Absatz klargestellt, dass die Aktie sich ihrem Rekordhoch…

ROUNDUP: Astrazeneca will auch 2026 mehr verdienen - Aktie auf Rekordhoch

CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca stellt sich nach einem schwungvollen Jahr auf weiteres Wachstum…

AstraZeneca’s growth engine stays on track despite cost pressures

AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN)  full-year results showed the pharmaceutical group navigating a challenging comparison period with a robust...…

FTSE 100 slips as Standard Chartered and BP weigh

The FTSE 100 slipped on Tuesday as investors digested a raft of corporate updates from companies including Barclays, AstraZeneca, and…

JEFFERIES stuft ASTRAZENECA auf Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Astrazeneca nach Zahlen zum vierten Quartal auf "Buy"…

BARCLAYS stuft ASTRAZENECA auf Overweight

LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Astrazeneca nach Zahlen auf "Overweight" mit einem Kursziel…

Astrazeneca will auch 2026 mehr verdienen - Vorsichtigere Wachstumsprognose

CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca stellt sich nach einem schwungvollen Jahr 2025 auf weiteres…

AstraZeneca lifts earnings as pipeline delivery and global expansion underpin growth

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) delivered strong full-year results for 2025, driven by solid commercial performance across all major regions and...…

Drugmaker AstraZeneca forecasts sales and profit growth in 2026

AstraZeneca on Tuesday forecast profit and sales growth in 2026, betting on demand for its cancer and cardiovascular treatments while…

AstraZeneca earnings up next after NYSE debut, China expansion By Investing.com

AstraZeneca earnings up next after NYSE debut, China expansion…

Why AstraZeneca is Investing $15bn in Chinese Manufacturing

AstraZeneca will invest US$15bn in China through 2030 to boost R&D, advanced manufacturing and next generation therapies for patients around…

Spotlight On Coca-Cola, Ford, AstraZeneca Earnings

…

FDA Rejects AZNs Saphnelo SubQ Formulation, Priority Tag to Datroway

AstraZeneca wins FDA priority review for Datroway in triple-negative breast cancer, while Saphnelo SC receives a complete response letter.…

Why Astrazeneca (AZN) Dipped More Than Broader Market Today

The latest trading day saw Astrazeneca (AZN) settling at $184.32, representing a -2.17% change from its previous close.…

FDA Rejects Self-Injected Version of AstraZeneca’s Lupus Drug

The US Food and Drug Administration rejected a subcutaneous version of AstraZeneca Plc’s lupus medicine that would make it easier…

Total Voting Rights

2 February 2026Transparency DirectiveVoting rights and capitalThe following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

AstraZeneca begins trading directly on the NYSE

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares start trading directly on the New York Stock Exchange today, establishing a harmonised global listing along...…

AstraZeneca begins trading directly on the NYSE

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares start trading directly on the New York Stock Exchange today, establishing a harmonised global listing along...…

AstraZeneca Shares to Start Trading in US After Listing Upgrade

It has said the move will give equal weight to its UK, Swedish and US listings. It reflects the…

AstraZeneca Shares Start Trading in US After Listing Upgrade

Shares of AstraZeneca Plc, the UK’s biggest drugmaker, started trading on the New York Stock Exchange on Monday following a…

Imfinzi recommended in EU for early gastric cancer

02 February 2026Imfinzi perioperative regimen recommended for approval in the EU byCHMP for patients with early gastric and gastroesophageal cancersRecommendation based on…

AstraZeneca begins trading on NYSE

02 February 2026AstraZeneca begins trading on the New York Stock ExchangeOrdinary shares now trade across the NYSE, LSE and STO under…

AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with Chinas tempting innovation

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.…

AstraZeneca obesity tie-up with CSPC seen as shrewd move

AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) licensing deal on Friday signals a plausible effort by the FTSE 100 group to grab a piece…

AstraZeneca strikes $1.2bn obesity drug deal with Chinas CSPC

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is paying $1.2 billion up-front to seal a tie-up with a Chinese pharma giant aimed at expanding…

Chinas CSPC Pharmaceutical inks deal with AstraZeneca for weight loss therapy

CSPC Pharmaceutical Group said on Friday it had entered an agreement with UK drugmaker AstraZeneca for the development of innovative…

Apple AAPL Q1 2026 Earnings Call Transcript

Image source: The Motley Fool.DateThursday, January 29, 2026 at 5 p.m. ETCall participantsChief Executive Officer — Timothy D. CookChief Financial…

AstraZeneca to invest £11bn in China after rowing back on UK expansion

Move comes after Britain’s biggest drugmaker’s dispute with government over drug pricing…

AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities

AstraZeneca has outlined plans to invest $15 billion in | AstraZeneca has outlined plans to invest $15 billion in China through…

AstraZeneca sets out $15 billion China investment during Starmer visit

UK drugmaker AstraZeneca said on Thursday it would invest $15 billion in China through 2030 to expand medicines manufacturing and…

Airbus, AstraZeneca and HSBC executives join UKs Starmer on high-stakes China trip

Executives from Airbus, AstraZeneca and HSBC are joining Prime Minister Keir Starmer on a rare China visit, highlighting the business…

AstraZeneca the top pick among European pharmas

Analysts at Citi see AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) as the top pick among European pharmaceutical firms. and rate the FTSE 100…

HSBC tops $300 billion market value for first time

Shares in HSBC rose as much as 3% to a new record high on Tuesday, briefly lifting the banks market…

Why Astrazeneca (AZN) Outpaced the Stock Market Today

Astrazeneca (AZN) closed at $94.23 in the latest trading session, marking a +1.38% move from the prior day.…

Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note

Astrazeneca (AZN) closed the most recent trading day at $96.34, moving +1.94% from the previous trading session.…

FTSE 100 hits fresh record high as miners rally

The FTSE 100 rose to a fresh record high on Wednesday as strong metals prices lifted miners, and AstraZeneca rose…

Stocks Slide on CPI, Traders Boost June Fed Rate-Cut Odds | The Close 1/13/2026

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after…

Übernahme: AstraZeneca kauft KI-Firma zur Beschleunigung der Medikamentenentwicklung

Die Künstliche Intelligenz soll neue Medikamente schneller finden. Es ist laut AstraZeneca die erste Übernahme eines KI-Unternehmens durch einen großen…

AstraZeneca: Oncology Dominance Justifies New All-Time Highs

…

Walmart To Join Nasdaq 100 on Jan. 20 as AstraZeneca Exits

Walmart Inc. will join the Nasdaq 100 Index, replacing AstraZeneca Plc, Nasdaq Global Indexes said Friday.…

Walmart to replace Astrazeneca on Nasdaq-100 By Reuters

Walmart to replace Astrazeneca on Nasdaq-100…

Walmart to replace Astrazeneca on Nasdaq-100

Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20,…

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know

Astrazeneca (AZN) concluded the recent trading session at $94.01, signifying a -1.21% move from its prior days close.…

AstraZeneca names Rick Suarez head of US biopharmaceuticals unit

AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the drugmakers…

JNJ vs. AZN: Which Drug Stock Comes Out on Top for Investors?

J&Js diversified pharma and MedTech strength stacks up against AstraZenecas oncology-led growth as investors weigh stability versus faster expansion.…

JP Morgan expects solid AstraZeneca quarter and reassuring outlook

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is set to deliver a solid finish to 2025 when it reports fourth-quarter results next month,…

Total Voting Rights

2 January 2026Transparency DirectiveVoting rights and capitalThe following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

The Zacks Analyst Blog Highlights Berkshire Hathaway, AstraZeneca, Intel, Kingsway Financial and BK Technologies

Berkshire Hathaway headlines new Zacks research reports, with strong insurance performance, cash strength and diversified growth drivers.…